DACT3 Is an Epigenetic Regulator of Wnt/β-Catenin Signaling in Colorectal Cancer and Is a Therapeutic Target of Histone Modifications

Xia Jiang, Jing Tan, Jingsong Li, Saul Kivimäe, Xiaojing Yang, Li Zhuang, Puay Leng Lee, Mark T.W. Chan, Lawrence W. Stanton, Edison T. Liu, Benjamin N.R. Cheyette, Qiang Yu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

220 Citations (Scopus)

Abstract

Genetic and epigenetic defects in Wnt/β-catenin signaling play important roles in colorectal cancer progression. Here we identify DACT3, a member of the DACT (Dpr/Frodo) gene family, as a negative regulator of Wnt/β-catenin signaling that is transcriptionally repressed in colorectal cancer. Unlike other Wnt signaling inhibitors that are silenced by DNA methylation, DACT3 repression is associated with bivalent histone modifications. Remarkably, DACT3 expression can be robustly derepressed by a pharmacological combination that simultaneously targets both histone methylation and deacetylation, leading to strong inhibition of Dishevelled (Dvl)-mediated Wnt/β-catenin signaling and massive apoptosis of colorectal cancer cells. Our study identifies DACT3 as an important regulator of Wnt/β-catenin signaling in colorectal cancer and suggests a potential strategy for therapeutic control of Wnt/β-catenin signaling in colorectal cancer.

Original languageEnglish
Pages (from-to)529-541
Number of pages13
JournalCancer Cell
Volume13
Issue number6
DOIs
Publication statusPublished - 10 Jun 2008
Externally publishedYes

Keywords

  • CELLCYCLE
  • DNA

Fingerprint

Dive into the research topics of 'DACT3 Is an Epigenetic Regulator of Wnt/β-Catenin Signaling in Colorectal Cancer and Is a Therapeutic Target of Histone Modifications'. Together they form a unique fingerprint.

Cite this